Approximately one third of UK residents will suffer from cancer at some point during their lives and, with current practice, about a half of these will receive radiotherapy as part of their treatment. Predominantly, this radiotherapy will be in the form of X-rays. Unfortunately, due to the profile of the energy deposition in tissue, it is very difficult to prevent damage to healthy tissue and, more importantly, to vital organs, the spinal cord and the brain, using X-rays, even employing the most modern delivery techniques. With beams of hadrons, for example protons or carbon ions, however, much of the energy deposition occurs in the so-called Bragg peak at the end of the hadron range. Although there is still energy loss before this peak, this is only a fraction of the total and, more importantly, there is very little after the peak. This makes it possible to minimise damage to healthy tissue and avoid it completely in vital areas of the body. There is an increasing body of clinical evidence demonstrating the benefits of therapy using hadron beams.

Unfortunately, in the UK this so-called hadron therapy is only available at one place, the Clatterbridge Centre for Oncology, and can only be used for treating tumours in the eye. The British Accelerator Science and Radiation Oncology Consortium believes this is simply not good enough. We are studying a novel technology for delivering hadron therapy which we will believe is superior to the existing techniques and will make hadron therapy possible in major hospitals in the UK.

Details of our plans can be found here.

Please note that this website is currently under development.

For more information, please contact: Rob Edgecock - Tel: +44 (0)1235 44 5089